Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations

被引:11
|
作者
van Dijk, Sabine J. [1 ]
Boontje, Nicky M. [1 ]
Heymans, Martijn W. [2 ]
ten Cate, Folkert J. [3 ]
Michels, Michelle [3 ]
dos Remedios, Cris [4 ]
Dooijes, Dennis [5 ]
van Slegtenhorst, Marjon A. [6 ]
van der Velden, Jolanda [1 ,7 ]
Stienen, Ger J. M. [1 ,8 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Physiol Lab, Inst Cardiovasc Res, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands
[3] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands
[4] Univ Sydney, Muscle Res Unit, Inst Biomed Res, Sydney, NSW 2006, Australia
[5] Med Ctr Utrecht, Utrecht, Netherlands
[6] Erasmus MC, Rotterdam, Netherlands
[7] ICIN Netherlands Heart Inst, Utrecht, Netherlands
[8] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands
来源
关键词
Cardiac muscle; Cross-bridge; Muscle contraction; MyBP-C mutation; BINDING-PROTEIN-C; KINASE-A PHOSPHORYLATION; HEART-FAILURE; TROPONIN-I; STRETCH ACTIVATION; F-ACTIN; MYOSIN; MUSCLE; ABLATION; GENE;
D O I
10.1007/s00424-013-1391-0
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Mutations in the MYBPC3 gene, encoding cardiac myosin binding protein C (cMyBP-C) are frequent causes of hypertrophic cardiomyopathy (HCM). Previously, we have presented evidence for reduced cMyBP-C expression (haploinsufficiency), in patients with a truncation mutation in MYBPC3. In mice, lacking cMyBP-C cross-bridge kinetics was accelerated. In this study, we investigated whether cross-bridge kinetics was altered in myectomy samples from HCM patients harboring heterozygous MYBPC3 mutations (MYBPC3(mut)). Isometric force and the rate of force redevelopment (k (tr)) at different activating Ca2+ concentrations were measured in mechanically isolated Triton-permeabilized cardiomyocytes from MYBPC3(mut) (n = 18) and donor (n = 7) tissue. Furthermore, the stretch activation response of cardiomyocytes was measured in tissue from eight MYBPC3(mut) patients and five donors to assess the rate of initial force relaxation (k (1)) and the rate and magnitude of the transient increase in force (k (2) and P (3), respectively) after a rapid stretch. Maximal force development of the cardiomyocytes was reduced in MYBPC3(mut) (24.5 +/- 2.3 kN/m(2)) compared to donor (34.9 +/- 1.6 kN/m(2)). The rates of force redevelopment in MYBPC3(mut) and donor over a range of Ca2+ concentrations were similar (k (tr) at maximal activation: 0.63 +/- 0.03 and 0.75 +/- 0.09 s(-1), respectively). Moreover, the stretch activation parameters did not differ significantly between MYBPC3(mut) and donor (k (1): 8.5 +/- 0.5 and 8.8 +/- 0.4 s(-1); k (2): 0.77 +/- 0.06 and 0.74 +/- 0.09 s(-1); P (3): 0.08 +/- 0.01 and 0.09 +/- 0.01, respectively). Incubation with protein kinase A accelerated k (1) in MYBPC3(mut) and donor to a similar extent. Our experiments indicate that, at the cMyBP-C expression levels in this patient group (63 +/- 6 % relative to donors), cross-bridge kinetics are preserved and that the depressed maximal force development is not explained by perturbation of cross-bridge kinetics.
引用
下载
收藏
页码:1619 / 1633
页数:15
相关论文
共 50 条
  • [1] Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations
    Sabine J. van Dijk
    Nicky M. Boontje
    Martijn W. Heymans
    Folkert J. ten Cate
    Michelle Michels
    Cris dos Remedios
    Dennis Dooijes
    Marjon A. van Slegtenhorst
    Jolanda van der Velden
    Ger J. M. Stienen
    Pflügers Archiv - European Journal of Physiology, 2014, 466 : 1619 - 1633
  • [2] MYBPC3 Mutations in Indian Patients With Hypertrophic Cardiomyopathy
    Wankhade, Varsha W.
    CIRCULATION RESEARCH, 2019, 125
  • [3] Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
    Toepfer, Christopher N.
    Wakimoto, Hiroko
    Garfinkel, Amanda C.
    McDonough, Barbara
    Liao, Dan
    Jiang, Jianming
    Tai, Angela C.
    Gorham, Joshua M.
    Lunde, Ida G.
    Lun, Mingyue
    Lynch, Thomas L.
    McNamar, James W.
    Sadayappa, Sakthivel
    Redwood, Charles S.
    Watkins, Hugh C.
    Seidma, Jonathan G.
    Seidman, Christine E.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (476)
  • [4] Prevalence of MYBPC3 Gene Mutations in Russian Patients with Hypertrophic Cardiomyopathy
    Klass, A. L.
    Krylova, N. S.
    Lysenko, A. V.
    Vlasov, I. N.
    Maslova, M. Yu.
    Salagaev, G. I.
    Kovalevskaya, E. A.
    Poteshkina, N. G.
    Shadrina, M. I.
    Slominsky, P. A.
    Filatova, E. V.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2023, 38 (01) : 16 - 20
  • [5] Prevalence of MYBPC3 Gene Mutations in Russian Patients with Hypertrophic Cardiomyopathy
    A. L. Klass
    N. S. Krylova
    A. V. Lysenko
    I. N. Vlasov
    M. Yu. Maslova
    G. I. Salagaev
    E. A. Kovalevskaya
    N. G. Poteshkina
    M. I. Shadrina
    P. A. Slominsky
    E. V. Filatova
    Molecular Genetics, Microbiology and Virology, 2023, 38 : 16 - 20
  • [6] How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Steven Marston
    O’Neal Copeland
    Katja Gehmlich
    Saskia Schlossarek
    Lucie Carrrier
    Journal of Muscle Research and Cell Motility, 2012, 33 : 75 - 80
  • [7] Identification of founder MYBPC3 gene mutations in hungarian patients with hypertrophic cardiomyopathy
    Tringer, A.
    Hategan, L.
    Csanyi, B.
    Borbas, J.
    Palinkas, E.
    Nagy, V.
    Hegedus, Z.
    Nagy, I.
    Forster, T.
    Sepp, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 55 - 55
  • [8] How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Marston, Steven
    Copeland, O'Neal
    Gehmlich, Katja
    Schlossarek, Saskia
    Carrrier, Lucie
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2012, 33 (01) : 75 - 80
  • [9] Prevalence and phenotypic characteristics associated with MyBPC3 mutations in patients with hypertrophic cardiomyopathy
    Ortiz, M.
    Hermida-Prieto, M.
    Rodriguez, I.
    Fernandez, X.
    Cazon, L.
    Barriales, R.
    Alvarino, I.
    Veira, E.
    Castro Beiras, A.
    Monserrat, L.
    EUROPEAN HEART JOURNAL, 2008, 29 : 55 - 56
  • [10] MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy
    O'Leary, Thomas S.
    Snyder, Julia
    Sadayappan, Sakthivel
    Day, Sharlene M.
    Previs, Michael J.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 127 : 165 - 173